Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „CYP3A4“
Suchtreffer
Begriffe & Kennungen
Akynzeo · 4.5 · Interaction with CYP3A4 substrates
Eintrag öffnenAkynzeo · 4.5 · Interaction with CYP3A4 substrates
Eintrag öffnenAkynzeo · 4.5 · Interaction with CYP3A4 substrates:
Eintrag öffnenAkynzeo · 4.5 · Netupitant is mainly metabolised by CYP3A4; therefore, co-administration with medicinal products that inhibit
Eintrag öffnenAkynzeo · 4.5 · Netupitant is mainly metabolised by CYP3A4; therefore, co-administration with medicinal products that inhibit
Eintrag öffnenAkynzeo · 4.5 · Netupitant is mainly metabolised by CYP3A4; therefore, co-administration with medicinal products that inhibit
Eintrag öffnenAkynzeo · 4.5 · Netupitant is mainly metabolised by CYP3A4; therefore, co-administration with medicinal products that inhibit
Eintrag öffnenAkynzeo · 4.5 · When netupitant/palonosetron capsules are used concomitantly with another CYP3A4 inhibitor, netupitant plasma
Eintrag öffnenAkynzeo · 4.5 · When netupitant/palonosetron sachets are used concomitantly with another CYP3A4 inhibitor, netupitant plasma c
Eintrag öffnenAlecensa · 4.5 · CYP substrates In vitro, alectinib and M4 show weak time-dependent inhibition of CYP3A4, and alectinib exhibit
Eintrag öffnenAlecensa · 4.5 · Effects of other medicinal products on alectinib Based on in vitro data, CYP3A4 is the primary enzyme mediatin
Eintrag öffnenAloxi · 4.5 · Palonosetron is mainly metabolised by CYP2D6, with minor contribution by CYP3A4 and CYP1A2 isoenzymes. Based o
Eintrag öffnenAloxi · 4.5 · Palonosetron is mainly metabolised by CYP2D6, with minor contribution by CYP3A4 and CYP1A2 isoenzymes. Based o
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Steady-state administration of ketoconazole (a strong inhibitor of CYP3A4) did not result in a clinically sign
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · The potential for ambrisentan to induce CYP3A4 activity was explored in healthy volunteers with results sugges
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.5 · 6 and after concomitant medicinal product particularly with strong CYP3A4 inducers (e.g. rifampicin, hypericum
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.5 · CYP3A4 inducers (anticonvulsant agents [e.g. carbamazepine, phenobarbital, phenytoin, fosphenytoin, primidone]
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.5 · CYP3A4 inhibitors Concomitant use of amlodipine with strong or moderate CYP3A4 inhibitors (protease inhibitors
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Vilanterol is a substrate of cytochrome P450 3A4 (CYP3A4). Concomitant administration of strong CYP3A4 inhibit
Eintrag öffnenApixaban Accord · 4.5 · 43 Inducers of CYP3A4 and P-gp Coadministration of apixaban with rifampicin, a strong inducer of both CYP3A4 a
Eintrag öffnen